| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 14.18 | 50.9% | 714.9% |
| Total Income | 14.18 | 50.9% | 714.9% |
| Expenditure | 26.37 | 4.9% | 59.7% |
| PBT | — | ||
| Net Profit | -12.77 | 492.9% | 80.3% |
| OPM | -85.93% | 98.88pp | |
| NPM | -90.04% | 101.30pp | |
| EPS | -0.04 | 500.0% | 77.8% |
Lexicon Pharmaceuticals Reports Q3 2025 Results
04 May 2026 · 4 May, 7:47 am
Summary
Lexicon Pharmaceuticals issued a press release on November 6, 2025, to report its financial results for the quarter ended September 30, 2025. The press release is included as an exhibit to the Form 8-K filing. The report details the company's operational and financial performance for the specified period.
Key Highlights
- 1
Lexicon Pharmaceuticals issued a press release to report financial results for the quarter ended September 30, 2025.
- 2
The press release is attached as Exhibit 99.1 to the Form 8-K.
- 3
The report includes information on the results of operation and financial condition for Q3 2025.
Informational and educational content only. Not investment advice.